1315PDevelopment and internal validation of a predictive nomogram of progression-free survival in well-differentiated stage IV gastroenteropancreatic neuroendocrine tumours treated with somatostatin analogues: GETNE-TRASGU study. (23rd October 2018) - Garcia-Carbonero, R; Alonso, V; Capdevila, J; Sanchez Canovas, M; Alonso, T; Benavent, M; Custodio, A; Crespo Herrero, G; Lopez, C; Hernando, J; Riesco Martinez, M C; Escudero, P; et al.